Costs of treatment of colorectal cancer in different settings in Germany

By Hieke Klaus   Kleeberg Ulrich   Stauch Martina   Grothey Axel  

The European Journal of Health Economics, Vol. 5, Iss. 3, 2004-09 ,pp. : 270-273

Springer Publishing Company

Access to resources Recommend Favorite

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

By Mastroianni Candida M.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe

By Zhao Zhongyun   Pelletier Elise   Barber Beth   Bhosle Monali   Wang Song   Gao Sue   Klingman David  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite

Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents

By DaCosta Byfield Stacey  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1071-1081

Informa Healthcare

Access to resources Recommend Favorite

FOLFOX-4 Stop and Go and Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 345-350

Karger

Access to resources Recommend Favorite